NDC 60505-6236

Deferoxamine mesylate

Deferoxamine Mesylate

Deferoxamine mesylate is a Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Deferoxamine Mesylate.

Product ID60505-6236_bd585bc2-1383-72b7-61c3-9e57591c05c2
NDC60505-6236
Product TypeHuman Prescription Drug
Proprietary NameDeferoxamine mesylate
Generic NameDeferoxamine Mesylate
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2021-11-05
Marketing CategoryANDA /
Application NumberANDA207384
Labeler NameApotex Corp.
Substance NameDEFEROXAMINE MESYLATE
Active Ingredient Strength500 mg/1
Pharm ClassesIron Chelating Activity [MoA],Iron Chelator [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 60505-6236-6

4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6236-6)
Marketing Start Date2021-11-05
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Deferoxamine mesylate" or generic name "Deferoxamine Mesylate"

NDCBrand NameGeneric Name
0409-2336Deferoxamine MesylateDeferoxamine Mesylate
0409-2337Deferoxamine MesylateDeferoxamine Mesylate
47781-623Deferoxamine mesylateDeferoxamine mesylate
47781-624Deferoxamine mesylateDeferoxamine mesylate
52609-4504Deferoxamine mesylateDeferoxamine mesylate
52609-4505Deferoxamine mesylateDeferoxamine mesylate
60505-6236Deferoxamine mesylateDeferoxamine mesylate
60505-6237Deferoxamine mesylateDeferoxamine mesylate
60505-6238Deferoxamine mesylateDeferoxamine mesylate
68083-172Deferoxamine mesylateDeferoxamine mesylate
68083-173Deferoxamine mesylateDeferoxamine mesylate
63323-597DeferoxamineDEFEROXAMINE MESYLATE
63323-599DeferoxamineDEFEROXAMINE MESYLATE
0078-0467Desferaldeferoxamine mesylate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.